The Impact of GLP-1 Weight Loss Drugs on Health and Market Dynamics
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
Stories and perspectives from Breathing.Food.
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
Abbott has unveiled Libre Assist, an AI-driven tool that allows users to photograph their meals and receive predictions about their glucose impact. Launched at CES 2026, this inno…
Lora Iannotti and Feng Jiao have been appointed as the first Lauren and Lee Fixel Distinguished Professors at Washington University, marking a significant step in addressing globa…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
Eli Lilly is targeting a revenue milestone of $100 billion by fiscal 2026, supported by strong growth in its incretin franchise and a bullish price target of $1,480. The company's…